Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Short term Debt (2024 - 2025)

Tandem Diabetes Care's Short term Debt history spans 2 years, with the latest figure at $40.7 million for Q1 2025.

  • For Q1 2025, Short term Debt changed N/A year-over-year to $40.7 million; the TTM value through Mar 2025 reached $40.7 million, changed N/A, while the annual FY2024 figure was $40.7 million, N/A changed from the prior year.
  • Short term Debt reached $40.7 million in Q1 2025 per TNDM's latest filing, roughly flat from $40.7 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $40.7 million in Q1 2025 to a low of $40.5 million in Q2 2024.